1. Home
  2. WSC vs GKOS Comparison

WSC vs GKOS Comparison

Compare WSC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WSC
  • GKOS
  • Stock Information
  • Founded
  • WSC 1944
  • GKOS 1998
  • Country
  • WSC United States
  • GKOS United States
  • Employees
  • WSC N/A
  • GKOS N/A
  • Industry
  • WSC Misc Corporate Leasing Services
  • GKOS Medical/Dental Instruments
  • Sector
  • WSC Industrials
  • GKOS Health Care
  • Exchange
  • WSC Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • WSC 4.8B
  • GKOS 5.7B
  • IPO Year
  • WSC N/A
  • GKOS 2015
  • Fundamental
  • Price
  • WSC $27.96
  • GKOS $101.43
  • Analyst Decision
  • WSC Buy
  • GKOS Strong Buy
  • Analyst Count
  • WSC 9
  • GKOS 13
  • Target Price
  • WSC $40.63
  • GKOS $135.15
  • AVG Volume (30 Days)
  • WSC 1.8M
  • GKOS 850.5K
  • Earning Date
  • WSC 07-31-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • WSC 0.99%
  • GKOS N/A
  • EPS Growth
  • WSC N/A
  • GKOS N/A
  • EPS
  • WSC 0.08
  • GKOS N/A
  • Revenue
  • WSC $2,368,088,000.00
  • GKOS $404,523,000.00
  • Revenue This Year
  • WSC N/A
  • GKOS $27.88
  • Revenue Next Year
  • WSC $5.14
  • GKOS $27.60
  • P/E Ratio
  • WSC $354.16
  • GKOS N/A
  • Revenue Growth
  • WSC N/A
  • GKOS 23.92
  • 52 Week Low
  • WSC $21.91
  • GKOS $77.10
  • 52 Week High
  • WSC $43.80
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • WSC 55.29
  • GKOS 58.72
  • Support Level
  • WSC $27.11
  • GKOS $96.04
  • Resistance Level
  • WSC $28.10
  • GKOS $101.32
  • Average True Range (ATR)
  • WSC 0.82
  • GKOS 3.48
  • MACD
  • WSC 0.08
  • GKOS 0.29
  • Stochastic Oscillator
  • WSC 71.24
  • GKOS 80.94

About WSC WillScot Mobile Mini Holdings Corp.

WillScot Holdings Corp designs, delivers, and services onsite, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company includes modular office complexes, mobile offices, portable storage containers, and others.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: